These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10312838)

  • 1. Optimal reimbursement health insurance and the theory of Ramsey taxation.
    Besley TJ
    J Health Econ; 1988 Dec; 7(4):321-36. PubMed ID: 10312838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The demand for episodes of treatment in the Health Insurance Experiment.
    Keeler EB; Rolph JE
    J Health Econ; 1988 Dec; 7(4):337-67. PubMed ID: 10312839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal payment systems for health services.
    Ellis RP; McGuire TG
    J Health Econ; 1990; 9(4):375-96. PubMed ID: 10109988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health insurance: the tradeoff between risk pooling and moral hazard.
    Manning WG; Marquis MS
    J Health Econ; 1996 Oct; 15(5):609-39. PubMed ID: 10164045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The demand for outpatient mental health care from nonspecialty providers.
    Horgan C; Salkever D
    Adv Health Econ Health Serv Res; 1987; 8():211-33. PubMed ID: 10312958
    [No Abstract]   [Full Text] [Related]  

  • 6. Demand for psychiatric services: a clinical episode model for specifying "the product".
    Goldman HH; Scheffler RM; Cheadle A
    Adv Health Econ Health Serv Res; 1987; 8():255-73. PubMed ID: 10312959
    [No Abstract]   [Full Text] [Related]  

  • 7. Ramsey pricing and supply-side incentives in physician markets.
    Wedig GJ
    J Health Econ; 1993 Dec; 12(4):365-84. PubMed ID: 10131752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supply and demand factors in the determination of Medicare expenditures.
    Rizzo JA
    Health Serv Res; 1992 Feb; 26(6):705-24. PubMed ID: 1737705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal commodity taxation with moral hazard and unobservable outcomes.
    Russo G
    Int J Health Care Finance Econ; 2003 Mar; 3(1):53-71. PubMed ID: 14626012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The demand for episodes of mental health services.
    Keeler EB; Manning WG; Wells KB
    J Health Econ; 1988 Dec; 7(4):369-92. PubMed ID: 10312840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reimbursement incentives for hospital care.
    Bunker JP; Schaffarzick RW
    Annu Rev Public Health; 1986; 7():391-409. PubMed ID: 3521650
    [No Abstract]   [Full Text] [Related]  

  • 12. Tax policy toward health insurance and the demand for medical services.
    Chernick HA; Holmer MR; Weinberg DH
    J Health Econ; 1987 Mar; 6(1):1-25. PubMed ID: 10282727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the supply of private hospital beds in the UK: private insurance, NHS pay beds, or NHS waiting list?
    Yuen PP
    Health Serv Manage Res; 1991 Nov; 4(3):216-29. PubMed ID: 10118703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of moral hazard revisited.
    Nyman JA
    J Health Econ; 1999 Dec; 18(6):811-24. PubMed ID: 10847936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to care and utilization among children: estimating the effects of public and private coverage.
    Selden TM; Hudson JL
    Med Care; 2006 May; 44(5 Suppl):I19-26. PubMed ID: 16625060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost of free health care for all Kenyans: assessing the financial sustainability of contributory and non-contributory financing mechanisms.
    Okungu V; Chuma J; McIntyre D
    Int J Equity Health; 2017 Feb; 16(1):39. PubMed ID: 28241826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Private and public health insurance: competition incentives for the control of health care costs.
    Reilly BJ; Fuhr JP
    Hosp Health Serv Adm; 1983; 28(1):58-68. PubMed ID: 10259101
    [No Abstract]   [Full Text] [Related]  

  • 18. Health incentives help clamp costs.
    Penzkover RC
    Pers J; 1989 Mar; 68(3):114, 116-8. PubMed ID: 10303322
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal cost reimbursement of health insurers to reduce risk selection.
    Kifmann M; Lorenz N
    Health Econ; 2011 May; 20(5):532-52. PubMed ID: 20572200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using RD design to understand heterogeneity in health insurance crowd-out.
    Koch TG
    J Health Econ; 2013 May; 32(3):599-611. PubMed ID: 23579024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.